Overview

Company Information

Cancer Genetics, Inc. is an emerging leader in DNA-based cancer diagnostics and services some of the most prestigious medical institutions in the world. Our tests target cancers that are difficult to diagnose and predict treatment outcomes. These cancers include hematological, urogenital and HPV-associated cancers. We also offer a comprehensive range of non-proprietary oncology-focused tests and laboratory services that provide critical genomic information to healthcare professionals as well as biopharma and biotech. We have established strong research collaborations with major cancer centers such as Memorial Sloan-Kettering, The Cleveland Clinic, Mayo Clinic and the National Cancer Institute. For further information, please see www.cancergenetics.com.

Stock Information

Symbol
Market
Last
Change
Volume
As of

View Stock Information

Upcoming Events

American Society for Clinical Pharmacology & Therapeutics (ASCPT)

Mar 3 2015 - Mar 7 2015 • New Orleans, LA

4th Quarter and Fiscal Year 2014 Conference Call

Mar 12 2015

Dial-In Information
U.S. Toll-Free: 877-407-4018
International: 201-689-8471
Conference ID: 13601913

Replay Information
U.S. Toll-Free: 877-870-5176
International: 858-384-5517
Conference ID: 13601913
Available through March 26, 2014

United States & Canadian Academy of Pathology

Mar 21 2015 - Mar 27 2015 • Boston, MA

Recent News

Contacts

Company

Cancer Genetics, Inc.
201 Route 17 North
2nd Floor
Rutherford, NJ 07070

Investor Relations

Life Science Advisors LLC
Michael Rice
646-597-6979